LU87799A1 - Composition d'acides desoxyribonucleiques depolymerises pour usage local dans les traitements cosmetiques de la peau et du corps - Google Patents

Composition d'acides desoxyribonucleiques depolymerises pour usage local dans les traitements cosmetiques de la peau et du corps Download PDF

Info

Publication number: LU87799A1
Authority: LU; Luxembourg
Prior art keywords: deoxyribonucleic acids; local; depolymerized; skin; swelling
Prior art date: 1989-09-07

Application number

LU87799A

Other languages

English (en)

French (fr)

Inventor

Giovanni Gazzani

Original Assignee

Crinos Industria Farmaco

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-09-07

Filing date

1990-09-06

Publication date

1991-02-18

1990-09-06 Application filed by Crinos Industria Farmaco filed Critical Crinos Industria Farmaco

1991-02-18 Publication of LU87799A1 publication Critical patent/LU87799A1/fr

Links

108020004414 DNA Proteins 0.000 title claims abstract description 35
102000053602 DNA Human genes 0.000 title claims abstract description 33
239000000203 mixture Substances 0.000 title claims abstract description 33
238000011282 treatment Methods 0.000 title claims description 22
239000002537 cosmetic Substances 0.000 title claims description 5
239000004480 active ingredient Substances 0.000 claims abstract description 10
210000003141 lower extremity Anatomy 0.000 claims abstract description 7
201000004700 rosacea Diseases 0.000 claims description 10
241001303601 Rosacea Species 0.000 claims description 9
230000000694 effects Effects 0.000 claims description 6
239000000499 gel Substances 0.000 claims description 6
239000006071 cream Substances 0.000 claims description 5
229960000643 adenine Drugs 0.000 claims description 4
229940104302 cytosine Drugs 0.000 claims description 4
229910052698 phosphorus Inorganic materials 0.000 claims description 4
239000011574 phosphorus Substances 0.000 claims description 4
229940113082 thymine Drugs 0.000 claims description 4
IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 3
230000008961 swelling Effects 0.000 claims description 3
229910052757 nitrogen Inorganic materials 0.000 claims description 2
208000035484 Cellulite Diseases 0.000 claims 2
208000032912 Local swelling Diseases 0.000 claims 2
206010049752 Peau d'orange Diseases 0.000 claims 2
230000036232 cellulite Effects 0.000 claims 2
230000007812 deficiency Effects 0.000 claims 2
239000008280 blood Substances 0.000 claims 1
230000036770 blood supply Effects 0.000 claims 1
230000002262 irrigation Effects 0.000 claims 1
238000003973 irrigation Methods 0.000 claims 1
239000002674 ointment Substances 0.000 claims 1
239000000546 pharmaceutical excipient Substances 0.000 claims 1
206010030113 Oedema Diseases 0.000 abstract description 6
230000000699 topical effect Effects 0.000 abstract 1
238000009472 formulation Methods 0.000 description 19
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
238000002474 experimental method Methods 0.000 description 11
241001465754 Metazoa Species 0.000 description 10
238000012360 testing method Methods 0.000 description 10
238000000034 method Methods 0.000 description 9
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 8
238000002360 preparation method Methods 0.000 description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 6
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 6
239000002304 perfume Substances 0.000 description 6
239000003755 preservative agent Substances 0.000 description 6
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 6
238000011156 evaluation Methods 0.000 description 5
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
230000001815 facial effect Effects 0.000 description 4
235000013305 food Nutrition 0.000 description 4
239000000126 substance Substances 0.000 description 4
ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 3
229930024421 Adenine Natural products 0.000 description 3
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 3
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
206010033546 Pallor Diseases 0.000 description 3
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
241000700159 Rattus Species 0.000 description 3
210000003423 ankle Anatomy 0.000 description 3
235000005911 diet Nutrition 0.000 description 3
230000037213 diet Effects 0.000 description 3
235000011121 sodium hydroxide Nutrition 0.000 description 3
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
206010007191 Capillary fragility Diseases 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
235000011187 glycerol Nutrition 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
239000000902 placebo Substances 0.000 description 2
229940068196 placebo Drugs 0.000 description 2
YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 2
-1 β-hydroxyethyl Chemical group 0.000 description 2
JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 description 1
RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
235000019489 Almond oil Nutrition 0.000 description 1
206010003497 Asphyxia Diseases 0.000 description 1
241001414890 Delia Species 0.000 description 1
244000257039 Duranta repens Species 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
206010015150 Erythema Diseases 0.000 description 1
206010056474 Erythrosis Diseases 0.000 description 1
208000032843 Hemorrhage Diseases 0.000 description 1
206010030124 Oedema peripheral Diseases 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
229920001214 Polysorbate 60 Polymers 0.000 description 1
229920002125 Sokalan® Polymers 0.000 description 1
HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000008168 almond oil Substances 0.000 description 1
230000002238 attenuated effect Effects 0.000 description 1
229960000686 benzalkonium chloride Drugs 0.000 description 1
235000019445 benzyl alcohol Nutrition 0.000 description 1
CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
239000008367 deionised water Substances 0.000 description 1
229910021641 deionized water Inorganic materials 0.000 description 1
230000008021 deposition Effects 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
239000012154 double-distilled water Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
231100000321 erythema Toxicity 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
150000002191 fatty alcohols Chemical class 0.000 description 1
229930003935 flavonoid Natural products 0.000 description 1
150000002215 flavonoids Chemical class 0.000 description 1
235000017173 flavonoids Nutrition 0.000 description 1
YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
229940100242 glycol stearate Drugs 0.000 description 1
244000144993 groups of animals Species 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
230000003779 hair growth Effects 0.000 description 1
238000011835 investigation Methods 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
230000003902 lesion Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
239000006210 lotion Substances 0.000 description 1
210000004705 lumbosacral region Anatomy 0.000 description 1
238000005259 measurement Methods 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
235000021590 normal diet Nutrition 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
229940049964 oleate Drugs 0.000 description 1
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
230000007170 pathology Effects 0.000 description 1
235000019271 petrolatum Nutrition 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
235000013824 polyphenols Nutrition 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
239000000047 product Substances 0.000 description 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
238000011158 quantitative evaluation Methods 0.000 description 1
IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
210000000813 small intestine Anatomy 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
229940087562 sodium acetate trihydrate Drugs 0.000 description 1
239000002904 solvent Substances 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
230000002792 vascular Effects 0.000 description 1
210000000216 zygoma Anatomy 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Dermatology (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Birds (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)
Compositions Of Macromolecular Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

LU87799A 1989-09-07 1990-09-06 Composition d'acides desoxyribonucleiques depolymerises pour usage local dans les traitements cosmetiques de la peau et du corps LU87799A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT8921650A IT1232318B (it)	1989-09-07	1989-09-07	Composizioni ad uso topico contenenti acidi nucleici depolimerizzati per la cosmesi della pelle e del corpo.

Publications (1)

Publication Number	Publication Date
LU87799A1 true LU87799A1 (fr)	1991-02-18

Family

ID=11184847

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU87799A LU87799A1 (fr)	1989-09-07	1990-09-06	Composition d'acides desoxyribonucleiques depolymerises pour usage local dans les traitements cosmetiques de la peau et du corps

Country Status (18)

Country	Link
US (1)	US5126331A (ja)
EP (1)	EP0416677B1 (ja)
JP (1)	JPH0399017A (ja)
KR (1)	KR970009581B1 (ja)
AT (1)	ATE98868T1 (ja)
AU (1)	AU631441B2 (ja)
BE (1)	BE1003350A3 (ja)
CH (1)	CH682804A5 (ja)
DE (1)	DE69005398T2 (ja)
DK (1)	DK0416677T3 (ja)
ES (1)	ES2026754A6 (ja)
FR (1)	FR2651434B1 (ja)
GR (1)	GR1000637B (ja)
IL (1)	IL94582A (ja)
IT (1)	IT1232318B (ja)
LU (1)	LU87799A1 (ja)
NZ (1)	NZ233987A (ja)
PT (1)	PT95211B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1252174B (it) *	1991-12-09	1995-06-05	Crinos Industria Farmaco	Oligodesossimibonucleotidi ad attivita' antiischemica e procedimenti per il loro ottenimento
AU6714094A (en) *	1993-04-28	1994-11-21	Ribozyme Pharmaceuticals, Inc.	Ocular delivery of nucleic acid
US5470577A (en) *	1993-07-07	1995-11-28	Trustees Of Boston University	Stimulation of tanning by DNA fragments or single-stranded DNA
JP2688116B2 (ja) *	1993-07-29	1997-12-08	ロレアル	メークアップ用組成物
IT1270602B (it) *	1994-07-12	1997-05-07	Indena Spa	Formulazioni a base di esculoside e loro uso in campo farmaceutico e cosmetico
US5858339A (en) *	1995-03-29	1999-01-12	L'oreal	Method for making up the eyes using deoxyribonucleic acid
DE19545107A1 (de) *	1995-12-04	1997-06-05	Beiersdorf Ag	Verwendung eines wirksamen Gehaltes an Adenosin in kosmetischen oder dermatologischen Zubereitungen
USRE37380E1 (en) *	1996-07-12	2001-09-18	Bertrand Piot	Method for making up the eyes using deoxyribonucleic acid
DE19815090A1 (de) *	1998-04-06	1999-10-14	Henkel Kgaa	Kosmetische Mittel
US6946144B1 (en) *	1998-07-08	2005-09-20	Oryxe	Transdermal delivery system
CA2365901A1 (en) *	1999-04-14	2000-10-19	Musc Foundation For Research Development	Tissue-specific and pathogen-specific toxic agents and ribozymes
US7704965B2 (en) *	2002-06-26	2010-04-27	The Penn State Research Foundation	Methods and materials for treating human papillomavirus infections
JP5025253B2 (ja) *	2006-03-31	2012-09-12	日生バイオ株式会社	基礎化粧品用配合剤及び基礎化粧品
US9358037B2 (en)	2007-06-26	2016-06-07	Roxwood Medical, Inc.	Method and apparatus for centering a microcatheter within a vasculature
SG11201505076UA (en)	2012-12-31	2015-07-30	Jrx Biotechnology Inc	Liquid topical pharmaceutical nano-emulsion formulations
US11260018B2 (en)	2015-09-17	2022-03-01	Jrx Biotechnology, Inc.	Approaches for improving skin hydration and moisturization
GB201703656D0 (en) *	2017-03-07	2017-04-19	Univ Sheffield	Wound healing medicament

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1361925A (fr) *	1963-02-27	1964-05-29		Nouvelle composition à usage capillaire
FR1603826A (en) *	1968-12-09	1971-06-07		Dna-and rna-contg cosmetic prods
DE2509531A1 (de) *	1975-03-05	1976-09-16	Thomae Gmbh Dr K	Antivirales mittel
JPS59134706A (ja) *	1983-01-19	1984-08-02	Kobayashi Kooc:Kk	化粧料
US4557934A (en) *	1983-06-21	1985-12-10	The Procter & Gamble Company	Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4885157A (en) *	1987-02-13	1989-12-05	Fiaschetti Mary G	Dermal cosmetic composition and applications therefor
IT1222701B (it) *	1987-09-23	1990-09-12	Crinos Industria Farmaco	Composizione ad uso topico avente attivita' tricogena,antiforfora ed antiseborroica
FR2609393A1 (fr) *	1988-02-23	1988-07-15	Serobiologiques Lab Sa	Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques comprenant une substance azotee, notamment aminoacides, oligo- ou polypeptides, proteines, et leurs derives, et composition pharmaceutique ou cosmetique ainsi preparee.

1989
- 1989-09-07 IT IT8921650A patent/IT1232318B/it active
1990
- 1990-06-01 IL IL9458290A patent/IL94582A/en not_active IP Right Cessation
- 1990-06-08 NZ NZ233987A patent/NZ233987A/en unknown
- 1990-07-20 AU AU59169/90A patent/AU631441B2/en not_active Ceased
- 1990-08-10 EP EP90202171A patent/EP0416677B1/en not_active Expired - Lifetime
- 1990-08-10 DE DE90202171T patent/DE69005398T2/de not_active Expired - Fee Related
- 1990-08-10 DK DK90202171.6T patent/DK0416677T3/da active
- 1990-08-10 AT AT90202171T patent/ATE98868T1/de not_active IP Right Cessation
- 1990-08-16 GR GR900100612A patent/GR1000637B/el unknown
- 1990-08-16 US US07/568,125 patent/US5126331A/en not_active Expired - Fee Related
- 1990-09-03 JP JP2230744A patent/JPH0399017A/ja active Pending
- 1990-09-05 PT PT95211A patent/PT95211B/pt not_active IP Right Cessation
- 1990-09-05 CH CH2881/90A patent/CH682804A5/it not_active IP Right Cessation
- 1990-09-06 LU LU87799A patent/LU87799A1/fr unknown
- 1990-09-07 KR KR90014173A patent/KR970009581B1/ko not_active Expired - Fee Related
- 1990-09-07 FR FR909011104A patent/FR2651434B1/fr not_active Expired - Fee Related
- 1990-09-07 ES ES9002332A patent/ES2026754A6/es not_active Expired - Fee Related
- 1990-09-07 BE BE9000864A patent/BE1003350A3/fr not_active IP Right Cessation

Also Published As

Publication number	Publication date
DK0416677T3 (da)	1994-01-31
FR2651434B1 (fr)	1993-08-06
PT95211A (pt)	1991-05-22
AU5916990A (en)	1991-03-14
GR1000637B (el)	1992-09-11
DE69005398T2 (de)	1994-04-14
JPH0399017A (ja)	1991-04-24
AU631441B2 (en)	1992-11-26
IT8921650A0 (it)	1989-09-07
FR2651434A1 (fr)	1991-03-08
KR910005877A (ko)	1991-04-27
CH682804A5 (it)	1993-11-30
GR900100612A (en)	1992-01-20
NZ233987A (en)	1992-10-28
BE1003350A3 (fr)	1992-03-03
US5126331A (en)	1992-06-30
PT95211B (pt)	1997-06-30
EP0416677B1 (en)	1993-12-22
KR970009581B1 (en)	1997-06-14
IT1232318B (it)	1992-01-28
ES2026754A6 (es)	1992-05-01
ATE98868T1 (de)	1994-01-15
IL94582A0 (en)	1991-04-15
EP0416677A1 (en)	1991-03-13
IL94582A (en)	1994-10-07
DE69005398D1 (de)	1994-02-03

Publication	Publication Date	Title
FR2651434A1 (fr)	1991-03-08	Composition d'acides desoxyribonucleiques depolymerises pour usage local dans les traitements cosmetiques de la peau et du corps.
CA2258800A1 (fr)	1998-10-29	Composition anti-oxydante et/ou anti-elastase a base d'huile de lupin
EP0275224A2 (fr)	1988-07-20	Complexes phospholipidiques d'extraits de Vitis vinifera, leur procédé de préparation et compositions pharmaceutiques et cosmétiques les contenant
FR2657256A1 (fr)	1991-07-26	Nouvelles preparations cosmetiques contenant un extrait de tourteaux de tournesol (helianthus annuus).
FR2651125A1 (fr)	1991-03-01	Compositions pharmaceutiques de type "pates a l'eau".
CA2663387C (fr)	2015-10-06	Composition a base de xanthoxyline et son utilisation en cosmetique
EP0643960A1 (fr)	1995-03-22	Utilisation pour le traitement des peaux mixtes d'une quantité efficace de substances actives
FR2585568A1 (fr)	1987-02-06	Compositions cosmetiques comprenant un lipide derive des cellules cornees
CA3258484A1 (fr)	2023-12-28	Cosmetic or dermatological composition comprising polylysine dendrimers and use thereof
EP0318369B2 (fr)	1995-03-22	Composition à base de phases lamellaires lipidiques hydratées ou de liposomes contenant de la tyrosine ou un dérivé de tyrosine et composition cosmétique ou pharmaceutique, notamment dermatologique, à activité pigmentante, l'incorporant
WO2012045974A2 (fr)	2012-04-12	Utilisation cosmétique d'un extrait de tropaeolum majus comme principe actif pour favoriser l'oxygénation du tissu cutané
EP0338459A2 (en)	1989-10-25	Composition for promoting hair growth in androgenetic alopecia and method thereof
FR2653014A1 (fr)	1991-04-19	Utilisation de glycoproteines extraites de bacteries gram (-) pour la fabrication de compositions cosmetiques ou dermatologiques et compositions les renfermant.
EP0595949B1 (fr)	1996-06-19	Compositions pour la pigmentation de la peau ou des cheveux contenant un extrait de marrubium vulgare
FR2649610A1 (fr)	1991-01-18	Composition cosmetique ou pharmaceutique et notamment dermatologique contenant de l'ampc ou ses derives en liposomes
Trivedi et al.	2022	Formulation and evaluation of pluronic-lecithin organogel containing natural moisturizing agent for xerosis
CH689373A5 (fr)	1999-03-31	Complexe hydratant et compositions cosmétiques le contenant.
JPH06192082A (ja)	1994-07-12	細胞膜老化改善剤
WO2000056278A1 (fr)	2000-09-28	Utilisation de la vitamine c ou analogues pour stimuler la synthese de cellules de la peau
CH647674A5 (fr)	1985-02-15	Composition capillaire pour le traitement des cheveux a base de stigmasterol et de liquide amniotique lyophilise purifie.
WO2018178604A1 (fr)	2018-10-04	Compositions cosmétiques comprenant une association d'ingrédients et leurs utilisations
WO2002074278A1 (fr)	2002-09-26	Composition topique comprenant une association de lipides furaniques d'avocat et d'isoflavones
WO2005099664A1 (fr)	2005-10-27	Composition cosmetique autobronzante
EP0729744A1 (fr)	1996-09-04	Composition cosmétiques pour la protection solaire
FR3159098A1 (fr)	2025-08-15	Complexe protecteur d’un pigment rouge et composition cosmétique ou dermatologique ou pharmaceutique comportant un pigment rouge et un tel complexe protecteur dudit pigment